Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity
RNA · 2024-05 · 30 (5) · 500-511
DOI: 10.1261/rna.079953.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 26.03.2024. Verfasst von Inga Jarmoskaite und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford University, Stanford, California 94305, USA inga.jarmoskaite@airna.com jin.billy.li@stanford.edu. Hauptthemen laut MEDLINE: Adenosine Deaminase, RNA Editing. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Innate immunity must be tightly regulated to enable sensitive pathogen detection while averting autoimmunity triggered by pathogen-like host molecules. A hallmark of viral infection, double-stranded RNAs (dsRNAs) are also abundantly encoded in mammalian genomes, necessitating surveillance mechanisms to distinguish “self” from “nonself.” ADAR1, an RNA editing enzyme, has emerged as an essential safeguard against dsRNA-induced autoimmunity. By converting adenosines to inosines (A-to-I) in long dsRNAs, ADAR1 covalently marks endogenous dsRNAs, thereby blocking the activation of the cytoplasmic dsRNA sensor MDA5. Moreover, beyond its editing function, ADAR1 binding to dsRNA impedes the activation of innate immune sensors PKR and ZBP1. Recent landmark studies underscore the utility of silencing ADAR1 for cancer immunotherapy, by exploiting the ADAR1-dependence developed by certain tumors to unleash an antitumor immune response. In this perspective, we summarize the genetic and mechanistic evidence for ADAR1's multipronged role in suppressing dsRNA-mediated autoimmunity and explore the evolving roles of ADAR1 as an immuno-oncology target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Stanford University, Stanford, California 94305, USA inga.jarmoskaite@airna.com jin.billy.li@stanford.edu.
- AIRNA Corporation, Cambridge, Massachusetts 02142, USA.
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NIMH NIH HHS
- National Institutes of Health
Zitieren
APA
Jarmoskaite, I., & Li, J. B. (2024). Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity. RNA, 30(5), 500-511. https://doi.org/10.1261/rna.079953.124
Vancouver
Jarmoskaite I, Li JB. Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity. RNA. 2024;30(5):500-511. doi:10.1261/rna.079953.124
BibTeX
@article{Jarmoskaite2024,
author = {Jarmoskaite, Inga and Li, Jin Billy},
title = {Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity},
journal = {RNA},
year = {2024},
volume = {30},
number = {5},
pages = {500--511},
doi = {10.1261/rna.079953.124}
}
EUVIMED